Award Title | Agency | Phase | Award amount | Start Date | End Date |
---|---|---|---|---|---|
ApoFasL: a Novel Immunotherapeutic for T1D
Apoimmune, Inc. Principal Investigator |
HHS | 1 | $422K | 08/06/07 | 01/31/09 |
Chimeric CD80-SA as a Novel Cancer Vaccine
Apoimmune, Inc. Principal Investigator |
HHS | 1 | $417K | 09/01/06 | 08/31/07 |
Chimeric CD80-SA as a Novel Cancer Vaccine
Apoimmune, Inc. Principal Investigator |
HHS | 1 | $352K | 09/27/05 | 08/31/06 |